Discovery of mutant IDH2 inhibitors for the treatment of cancer

被引：0
|
作者：
Travins, Jeremy M. [1 ]
Popovici-Muller, Janeta [1 ]
DeLaBarre, Byron [2 ]
Gross, Stefan [2 ]
Yang, Hua [4 ]
Wang, Fang [3 ]
Yen, Katherine E. [3 ]
Salituro, Francesco G. [1 ]
Saunders, Jeffrey O. [1 ]
Dang, Lenny [2 ]
Biller, Scott A. [1 ]
机构：
[1] Agios Pharmaceut, Dept Chem, Cambridge, MA 02139 USA
[2] Agios Pharmaceut, Dept Biochem, Cambridge, MA 02139 USA
[3] Agios Pharmaceut, Dept Biol, Cambridge, MA 02139 USA
[4] Agios Pharmaceut, Dept Drug Metab & Pharmacokinet, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] IDH2 Mutation in a Patient with Metastatic Colon Cancer
    Zhang, Bing M.
    Zehnder, James L.
    Suarez, Carlos J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1991 - 1992
  • [32] The Impact of Clonal Architecture of IDH1 and IDH2 Mutant Cases on the Biology of Myeloid Malignancies
    Thota, Swapna
    Makishima, Hideki
    Przychodzen, Bartlomiej P.
    Viny, Aaron D.
    Patel, Bhumika J.
    Radivoyevitch, Tomas
    Sekeres, Mikkael A.
    Carraway, Hetty E.
    Haferlach, Torsten
    Ogawa, Seishi
    Maciejewski, Jaroslaw P.
    BLOOD, 2014, 124 (21)
  • [33] A new era after a long wait: Vorasetinib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma
    Silvani, Antonio
    Franceschi, Enrico
    TUMORI JOURNAL, 2024, 110 (03): : 160 - 161
  • [34] Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
    Wang, Fang
    Travins, Jeremy
    DeLaBarre, Byron
    Penard-Lacronique, Virginie
    Schalm, Stefanie
    Hansen, Erica
    Straley, Kimberly
    Kernytsky, Andrew
    Liu, Wei
    Gliser, Camelia
    Yang, Hua
    Gross, Stefan
    Artin, Erin
    Saada, Veronique
    Mylonas, Elena
    Quivoron, Cyril
    Popovici-Muller, Janeta
    Saunders, Jeffrey O.
    Salituro, Francesco G.
    Yan, Shunqi
    Murray, Stuart
    Wei, Wentao
    Gao, Yi
    Dang, Lenny
    Dorsch, Marion
    Agresta, Sam
    Schenkein, David P.
    Biller, Scott A.
    Su, Shinsan M.
    de Botton, Stephane
    Yen, Katharine E.
    SCIENCE, 2013, 340 (6132) : 622 - 626
  • [35] Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance
    Kats, Lev M.
    Reschke, Markus
    Taulli, Riccardo
    Pozdnyakova, Olga
    Burgess, Kerri
    Bhargava, Parul
    Straley, Kimberly
    Karnik, Rahul
    Meissner, Alexander
    Small, Donald
    Su, Shinsan M.
    Yen, Katharine
    Zhang, Jiangwen
    Pandolfi, Pier Paolo
    CELL STEM CELL, 2014, 14 (03) : 329 - 341
  • [36] IDH2 inhibition in AML
    Stein, Eytan M.
    BLOOD, 2023, 141 (15) : 1896 - 1896
  • [37] IDH2 inhibition in AML
    Stein, Eytan M.
    BLOOD, 2023, 141 (02) : 124 - 125
  • [38] Mutations of IDH1 and IDH2 are not detected in brain metastases of colorectal cancer
    Holdhoff, Matthias
    Parsons, D. Williams
    Diaz, Luis A., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (02) : 297 - 297
  • [39] IDH1 and IDH2 Mutations in Gliomas
    Adam L. Cohen
    Sheri L. Holmen
    Howard Colman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [40] IDH1 and IDH2 Mutations in Chondrosarcomas
    Nafa, K.
    Agaram, N. P.
    Borsu, L.
    Schwartz, G.
    Healey, J.
    Ladanyi, M.
    Hameed, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 700
12345